Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.11. Revenue for the quarter came in at $9.2 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick
• Ryman Hospitality closes $1.38B Grande Lakes Orlando deal